“Integrated Computational Design, Green Synthesis, and Characterization of 3,4-Dihydropyrimidine Derivatives Targeting Enoyl-Acyl Carrier Protein Reductase for Tuberculosis Treatment” (2026) International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). doi:10.33974/bnb32f45.